DOI: 10.1128/mBio.03336-20
Article Information
PubMed
Published By
History
- Received November 24, 2020
- Accepted February 25, 2021
- Published online April 6, 2021.
Copyright & Usage
Copyright © 2021 Peñaloza et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Jessica Scoffield, Invited Editor, University of Alabama at Birmingham
- Larry S. McDaniel, Editor, University of Mississippi Medical Center
Author Information
- Hernán F. Peñalozaa,
- Tolani F. Olonisakina,
- William G. Baina,
- Yanyan Qua,
- Rick van der Geesta,
- Jill Zupetica,
- Mei Hulvera,
- Zeyu Xionga,
- Michael W. Newsteadb,
- Chunbin Zoua,
- Jonathan K. Aldera,
- Joel A. Ybec,
- Theodore J. Standifordb,
- Janet S. Leea
- aAcute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- bPulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA
- cDepartment of Environmental and Occupational Health, School of Public Health, Indiana University, Bloomington, Indiana, USA
- Address correspondence to Janet S. Lee, leejs3{at}upmc.edu.
Citation Peñaloza HF, Olonisakin TF, Bain WG, Qu Y, van der Geest R, Zupetic J, Hulver M, Xiong Z, Newstead MW, Zou C, Alder JK, Ybe JA, Standiford TJ, Lee JS. 2021. Thrombospondin-1 restricts interleukin-36γ-mediated neutrophilic inflammation during Pseudomonas aeruginosa pulmonary infection. mBio 12:e03336-20. https://doi.org/10.1128/mBio.03336-20.
